MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Explicit movement control in functional movement disorders is characterized by reduced lateralized beta desynchronisation

    T. Teodoro, A. Meppelink, S. Little, A. Macerollo, R. Grant, M. Edwards (London, United Kingdom)

    Objective: To test whether beta power remains abnormally raised during motor preparation in functional movement disorders (FMD) patients. Background: Excessive attention towards movement control is…
  • 2017 International Congress

    Disappearance of the clinical and imaging manifestations in Wilson’s disease after controlled therapy with tetrathiomolybdate and zinc

    I. Posada, C. Garfia, F. Ostos, A. Ramos (Madrid, Spain)

    Objective: To present a case with Wilson’s disease (WD) whose neurological and imaging alterations disappeared after ammonium tetrathiomolybdate (AT) and zinc acetate (Zn) controlled therapy. …
  • 2017 International Congress

    Restless legs syndrome in pregnancy: frequency and impact on quality of life and sleep

    S. Telarovic, L. Condic, I. Telarovic (Zagreb, Croatia)

    Objective: To determine the frequency of restless legs syndrome (RLS) in pregnant women and its impact on quality of sleep (QoS) and quality of life…
  • 2017 International Congress

    PDSS: A Novel Mobile-based Parkinson Disease Severity Score

    A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)

    Objective: To propose a novel mobile-based Parkinson Disease Severity Score (PDSS) to provide high resolution and objective severity monitoring for patients in the home setting.…
  • 2017 International Congress

    Personal KinetiGraph (PKG) for Parkinson’s Disease: Experience at a Tertiary Care Center

    V. Sharma, A. Fowler, K. Lyons, R. Pahwa (Kansas City, KS, USA)

    Objective: To assess objective measurements by Personal KinetiGraph (PKG) in Parkinson’s disease (PD) patients and compare them to self-reported symptoms.   Background: Personal Kinetigraph (PKG)…
  • 2017 International Congress

    Neuroprotection and Alleviation of Parkinsonian Phenotypes by Ayurvedic Herbs

    S. Singh, J. Prakash, S. Yadav (Varanasi, India)

    Objective: Our laboratory has focused on the herbal treatment of Parkinson’s disease especially by the above two common herbs Withania somnifera (Ws) and Mucuna pruriens…
  • 2017 International Congress

    More effective rTMS site for the freezing of gait in Parkinson’s disease

    S.Y. Kang, S.J. Kim (Hwaseong, Republic of Korea)

    Objective: The aim of study is to find brain stimulation areas showing more effective response. Background: Freezing of gait (FOG) is frustrating problem in Parkinson’s…
  • 2017 International Congress

    Intracerebroventricular administration of dopamine: A new therapeutic concept for Parkinson’s disease?

    C. LALOUX, F. GOUEL, C. LACHAUD, K. Timmerman, A. Jonneaux, C. Moreau, R. BORDET, J.-c. DEVEDJIAN, D. DEVOS (LILLE, France)

    Objective: In this study, we aim to demonstrate that continuous i.c.v. infusion of dopamine close to the striatum is a feasible and highly efficient treatment…
  • 2017 International Congress

    Prevalence of tremor in Multiple Sclerosis in Isfahan, Iran

    M. Salari, M. Etemadifar, O. Mirmosayyeb (Isfahan, Islamic Republic of Iran)

    Objective: To evaluate prevalence of tremor in Multiple sclerosis in Isfahan Background: Multiple sclerosis (MS) is demyelinating disease of central nervous system (CNS), affecting mostly…
  • 2017 International Congress

    Head tremor in supine position does not differentiate essential tremor and cervical dystonia

    E. Ruzicka, R. Krupicka, T. Duspivova, O. Ulmanova, P. Holly, V. Cejka, J. Rusz, R. Jech (Praha, Czech Republic)

    Objective: Using objective instrumental methods, we aimed to verify the clinical utility of sitting/supine test and other clinical features to differentiate between ET and DT.…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley